scholarly article | Q13442814 |
P50 | author | Patricia P Katz | Q91750245 |
Edward Yelin | Q91988470 | ||
Lindsey A. Criswell | Q67485118 | ||
Jinoos Yazdany | Q88617667 | ||
Laura Trupin | Q88617670 | ||
P2093 | author name string | Sara G Murray | |
Laura J Julian | |||
Rachel Kaiser | |||
P2860 | cites work | The CES-D Scale: A Self-Report Depression Scale for Research in the General Population | Q26778378 |
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus | Q28213684 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities | Q33731244 | ||
Work dynamics among persons with systemic lupus erythematosus | Q33871651 | ||
Impact of memory impairment on employment status in persons with systemic lupus erythematosus | Q33871723 | ||
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites | Q33897009 | ||
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study | Q34017775 | ||
The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus | Q34335863 | ||
A review of the sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value? | Q36841752 | ||
Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus | Q36995068 | ||
Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus | Q37019825 | ||
Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus | Q37036848 | ||
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort | Q37137321 | ||
Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility--Reykjavik study | Q37306134 | ||
History of coronary heart disease and cognitive performance in midlife: the Whitehall II study | Q37339994 | ||
Norms for letter and category fluency: demographic corrections for age, education, and ethnicity | Q38449676 | ||
Cognitive impairment after stroke: clinical determinants and its associations with long-term stroke outcomes | Q40643537 | ||
Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 | ||
Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates | Q43425230 | ||
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. | Q43626449 | ||
Effects of age and hypertension status on cognition: the Veterans Affairs Normative Aging Study | Q45332910 | ||
Benton Controlled Oral Word Association Test: reliability and updated norms. | Q45941429 | ||
Hypertension and the brain: vulnerability of the prefrontal regions and executive functions | Q48116852 | ||
Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus | Q48312290 | ||
Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension | Q48429368 | ||
"Subcortical" cognitive impairment in patients with systemic lupus erythematosus. | Q49049719 | ||
Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. | Q50625463 | ||
Validation of a systemic lupus activity questionnaire (SLAQ) for population studies | Q50765174 | ||
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. | Q51069301 | ||
Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures. | Q51973262 | ||
The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. | Q52169153 | ||
General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus | Q57753752 | ||
Cardiovascular risk factors and cognitive decline in middle-aged adults | Q60692491 | ||
Cognitive impairment in patients with systemic lupus erythematosus | Q68136504 | ||
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus | Q77352546 | ||
P433 | issue | 9 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
cardiovascular disease | Q389735 | ||
cognitive dysfunction | Q57859955 | ||
P304 | page(s) | 1328-1333 | |
P577 | publication date | 2012-09-01 | |
P1433 | published in | Arthritis Care and Research | Q15754720 |
P1476 | title | Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus | |
P478 | volume | 64 |
Q51120688 | A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex. |
Q64099017 | Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus |
Q39644309 | Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction |
Q27016554 | Cardiovascular disease in lupus: insights and updates |
Q54968810 | Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction. |
Q92800609 | Efficacy of Acceptance and Commitment Therapy in Reducing Disappointment, Psychological Distress, and Psychasthenia among Systemic Lupus Erythematosus (SLE) Patients |
Q28070338 | Multimorbidity in rheumatic conditions |
Q38247180 | Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers |
Q41128018 | Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE. |
Q38255794 | Noradrenaline transmission reducing drugs may protect against a broad range of diseases |
Q55514340 | The association between systemic lupus erythematosus and dementia A meta-analysis. |
Q28072610 | The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus |
Search more.